FDA clears Medivance's patient cooling device
This article was originally published in Clinica
Executive Summary
Medivance's Arctic Sun 5000, a therapeutic temperature management device, has received 510(k) clearance from the US FDA. The noninvasive patient cooling system monitors core body temperature and can maintain a patient's temperature between 32 and 38.5°C. This could minimise damage to the heart and brain in patients who have suffered a traumatic event, Medivance claims. The device consists of ArcticGel pads, which are placed on the patient's body, a temperature probe, and a touch-screen control module. It is more precise than conventional cooling methods such as ice packs and water blankets, according to the Louisville, Colorado-based company.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.